Methods For The Treatment Of Her2 Amplified Cancer
Patent No. EP3033079 (titled "Methods For The Treatment Of Her2 Amplified Cancer") was filed by Pharmacyclics on Aug 12, 2014. The application was issued on Oct 31, 2018.
Patent Summary
Synthesis and kinase activity of a human cancer cell line that suppresses the activity of HER2 and other related signaling pathways. The cell line contains two kinase genes coding for inhibition of each kinase.
Patent Family
Patent Oppositions
Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
Dossier Documents
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents
EP3033079
- Application Number
- EP14835935A
- Filing Date
- Aug 12, 2014
- Status
- Revoked
- Jun 25, 2021
- Publication Date
- Oct 31, 2018
- External Links
- Slate, Register , Google Patents